Our New Director of the Cardiovascular Center, Ivor J. Benjamin MD, FAHA, FACC, is a Professor of Medicine at Froedtert Hospital, and the Medicial College of Wisconsin. A board-certified specialist and consultant in internal medicine and cardiology, Dr. Benjamin’s clinical interests are general cardiology, inheritable heart failure, and myocardial infarction.
Read More...
Dr. John A. Auchampach, PhD interests lie in Molecular Pharmacology and Cardiovascular Pharmacology.
Our broad goals include the development of computational technology for predicting and analyzing the behavior of biological systems and guiding engineering-based manipulations of biological systems...
The Beyer laboratory focuses on the study of small blood vessels that control blood flow to the heart and adipose of humans and the role of these vessels in cardiovascular diseases such as hypertension, coronary artery disease (CAD) and atherosclerosis.
Dr. Aron Geurts research efforts in his laboratory are being driven by his interests in three programmatic areas related to genetic manipulation of stem cells and whole animals for the annotation of gene function, tissue engineering, and cellular therapeutics related to human disease.
The research in Dr. Goldspink's lab centers around two thematic areas. 1. Improving cardiac muscle contractile function during disease and failure. 2. Enhancing cardiac repair and regeneration using stem cells and biomimicry. Intersecting these two areas of cardiac muscle function and biology is the influence of insulin-like growth factor-1 isoforms and their function.
Dr. David D. Gutterman's interest is in Vascular Biology with a Focus on Human Coronary Vascular Function
Dr. David R. Harder, PhD, Professor of Physiology, Associate Dean for Research, Kohler Co. Endowed Chair. Research areas include Cardiovascular Physiology, Neurophysiology, Molecular and Cellular Physiology.
John Imig's laboratory specializes in building and implementing genomic "tools" in the whole animal. Our goal is to link genomic tools to physiology for discovering the genetic basis of disease, including end stage renal disease (rat and human), hypertension (rat), insulin dependent diabetes mellitus (rat), syndrome-X (rat), left ventricular hypertrophy, myocardial infarction (rat and human) and various cardiac malformations (human).
Dr. Elizabeth R. Jacobs longstanding interest has been in endogenous factors which control pulmonary vascular tone.
Dr. Konduri's main focus is Fetal Pulmonary Circulation and Persistent Pulmonary Hypertension (PPH)
Dr. Scott Levick's research focus is in regards to myocardial remodeling, referring to alterations in the cellular and extracellular components of the heart.
My research focus is toward understanding the mechanisms underlying angiogenesis, which is the stimulation of new blood vessel growth. These new blood vessels have the potential to restore blood flow to previously ischemic muscle and skin, with the goal of reducing pain and tissue breakdown.
His research interests include strategies for reducing complications of immune suppression necessary after organ transplantation, and the use of stem cell-based therapies for the treatment of organ rejection and heart and lung failure.
Dr. Meetha M. Medhora's focus is on the effects of ionizing radiation on the vasculature of the lungs.
Daisy Sahoo's main research interest is the role of scavenger receptor BI (SR-BI) in the selective uptake and hydrolysis of cholesteryl esters.
Dr. Venkatesh Sampath's research focuses on the role of innate immune receptors in the causation of diseases of preterm infants.
The Strande laboratory is driven to investigate the intersection of coagulation, inflammation and cardiovascular disease. The primary focus is to study how thrombin and its receptors, PAR1 and PAR4, contribute to the pathogenesis of ischemic and dilated cardiomyopathy.
Dr. Michael E. Widlansky's human vascular research laboratory has been formed to foster collaboration with investigators from other disciplines interested in the impact of vascular function on disease states relevant to their fields of interest.
Dr. Carol L. Williams' research focuses on the biochemical signaling pathways and cellular processes regulated by the Ras and Rho families of small GTPases.
Dr. David X. Zhang's research is to understand the cellular mechanisms by which the endothelium regulates blood vessel tone in both normal physiological conditions and disease states, such as ischemic heart disease and hypertension.